Thats why your program includes human support and digital tools designed to help you build healthier behaviors
The pivotal Phase 2 trial a 48-week study published in The New England Journal of Medicine in 2023 produced these results in adults with obesity (and no diabetes), at the highest dose of 12 mg weekly: Average weight loss of around 24% from baseline A clear dose-response, with even the 4 mg dose producing roughly 17% weight loss Continued weight loss right up to the 48-week endpoint, with no plateau in sight For context, similar Phase 2 data for Wegovy showed around 15% weight loss at 68 weeks
Fiber matters too, as it may help ease common GLP-1 side effects like constipation or diarrhea
Someone may start out discussing interventions with solid evidence behind them, but if you got to come out with a podcast a week, at some point, you got to start reaching further and further afield for new topics or new exciting things, McGuire said
Generally well tolerated in veterinary studies
At Klinic, we connect you with licensed healthcare providers who specialize in weight loss treatments like tirzepatide